Purpose of the Review Outpatient practice sites prescribe more antibiotics than any other healthcare setting contributing to the increasing rate of drug-resistant infections in the USA. Until the release of the Centers for Disease Control and Prevention’sCoreElementsin 2016, outpatient antimicrobial stewardship (AMS) was largely overlooked. The current review seeks to discuss recent AMS interventions for uncomplicated urinary tract infection (UTI) in the outpatient setting and how they relate to the core elements. Recent Findings Evidence-based methods for UTI in the outpatient setting include pharmacist-review of urine cultures, provider education, clinical decision support, sus- ceptibility testing, and formulary restriction. These interventions improve guideline adherence and decrease fluoroquinolone use. Additional improvements in outcomes occur when strategies are combined compared to implementation of a single intervention alone. Summary There is insufficient evidence to universally recommend one intervention for outpatient practice. Studies are limited by size and design in addition to the need for 292 Antimicrobial Stewardship (A Pakyz, Section Editor) validation across the spectrum of outpatient settings. Therefore, outpatient stewardship teams should consider which strategy is most feasible and effective for their respective site. Most importantly, it is still unknown if improvements in adherence to clinical guidelines and reductions of fluoroquinolone use
Current Treatment Options in Infectious Diseases – Springer Journals
Published: Feb 13, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud